| Common Name | AN100226,AN100226,BG00002 |
|---|---|
| Synonyms | CD49D;IA4 |
| Applications | Flow Cyt |
| Recommended Dilutions | Flow Cyt 1:10 |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Host Species | Humanized |
| IgG type | IgG4 |
| Reactivity | Human |
| Target | |
| Uniprot ID | P13612 |
| Description | Anti-ITGA4 (natalizumab biosimilar) mAb |
| Delivery | In Stock |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Usage | Research use only |
Anti-ITGA4 (natalizumab biosimilar) mAb
Price: 50μg $82.00 ; 100 μg $162.00
Product Data
Images
Figure 1. Anti-ITGA4 (natalizumab biosimilar) mAb on SDS-PAGE under non-reducing (NR) and reducing (R) conditions.
Figure 1. Flow cytometry analysis with 15 μg/mL Anti-ITGA4 (natalizumab) mAb (BME100074) on Expi293 cells transfected with Human ITGA4 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).